Aβ42/40 Ratio (Plasma)
The plasma amyloid beta 42/40 ratio measures two fragments of the amyloid protein central to Alzheimer's disease, whose balance shifts as amyloid accumulates in the brain. A longevity practice uses this emerging blood test as a non-invasive window into cerebral amyloid status.
What It Measures
Plasma amyloid beta 42/40 ratio.
Optimal vs. Lab Range
Target range for optimal health and longevity based on research.
Population-based reference range from standard labs.
Why It Matters
Low ratio reflects cerebral amyloid deposition.
When Low
Low → amyloid deposition likely.
When Optimal
High → low amyloid burden.
When High
—
How to Optimize
Aggressive vascular risk reduction, sleep, exercise, MIND diet.
Key Interventions & Linked Compounds
Strong (8/10)Key Interventions
Linked Compounds & Supplements
Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.
Ordering Notes
Specimen
Serum or plasma (venous draw)
Patient prep
No fasting required. Maintain usual diet and medications unless advised.
Recommended cadence
Re-test every 3–6 months when actively optimizing; annually for monitoring.
Reporting unit
ratio
Pre-analytic notes
Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.
Recommended Follow-Up Actions
- 1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Aβ42/40 Ratio (Plasma).
- 2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
- 3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
- 4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
- 5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.
Quick Actions
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation